Skip to main content

Table 1 Trial management

From: A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin® (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design

Trial Operations Committee  
Adnan Tufail Chief Investigator, Moorfields Eye Hospital, London, UK
Praveen J Patel Principal Investigator, Moorfields Eye Hospital, London, UK
Laura Henderson (Mrs Ola Segun-Odumosu from March 2008) Trial Manager, Moorfields Eye Hospital, London, UK
Trial Steering Committee  
Astrid Fletcher Professor of Epidemiology and Ageing, London School of Hygiene and Tropical Medicine, London, UK
Adnan Tufail Chief Investigator, Moorfields Eye Hospital, London, UK
Catey Bunce Trial Statistician, Moorfields Eye Hospital, London, UK
Praveen J Patel Principal Investigator, Moorfields Eye Hospital, London, UK
Richard Wormald Consultant Ophthalmologist, Moorfields Eye Hospital, London, UK
Data Monitoring Committee  
Catey Bunce Trial Statistician, Moorfields Eye Hospital, London, UK
Marion Campbell Professor of Health Services Research, University of Aberdeen, UK
Robyn Guymer Professor of Ophthalmology, University of Melbourne, Australia
Frank G. Holz Professor of Ophthalmology, University of Bonn, Germany